Opinion · 2022
Conference abstractPublished 1 Oct 2012
MCT4 enables MSCs to improve engraftment in the ischemic wound environment and enhances MSC-based cell therapy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
M esenchymal stem cell (MSC) transplantation after myocardial infarction holds much promise as a means to regenerate lost cardiac tissue and preserve cardiac function. However, a significantly large portion of cells transplanted into the injured heart die shortly after delivery due to hypoxic wound microenvironment. Poor stem cell survival and engraftment in the host tissue is a major impediment in the progress of stem cell therapy. Although, MSCs have been shown to perform better in hypoxia there are huge gaps in our understanding of the metabolic responses of MSCs to hypoxia. To address this issue, gene expression analysis was performed which showed an upregulation of key glycolytic enzymes (hexokinase and enolase) and the enzymes regulating the switch from aerobic to anaerobic respiration (aldolase, LDHA, PDK1, and PDK3) in MSCs subjected to hypoxia. Interestingly, considerable upregulation of transcript and protein levels of monocarboxylate transporter 4 (MCT4) were identified in hypoxic compared to normoxic MSCs. MCT4 belongs to a family of proton-linked monocarboxylate transporters and facilitates the efflux of lactate across the plasma membrane. Since accumulation of lactate in the cells will cause acidosis and ultimately cell death, upregulation of MCT4 suggests that it helps in MSC homeostasis maintenance and survival by extruding out lactate. MSCs overexpressing MCT4 were able to maintain low levels of lactate in hypoxia and MCT4-knockdown MSCs showed accumulation of lactate in hypoxic microenvironment. Knocking down MCT4 abrogated MSC engraftment while MSCs overexpressing MCT4 engrafted better in our sponge model of tissue repair. These results indicate the exclusive role of MCT4 in lactate efflux and to preserve the integrity of MSCs in hypoxia and can be exploited in order to enhance the therapeutic potential of MSCs
Subjects
BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 25 Mar 2019
Receptor masking bax antagonism and licl supplementation improves homing and engraftment of bone marrow cells
Conference abstract · 24 Jun 2014
Cell-based therapy for hypoxic-ischemic injury in the preterm brain
Commentary · 2014
NK Cells and MSCs: Possible Implications for MSC Therapy in Renal Transplantation
Research article · 2014
IFNGamma Priming Protects Fetal and Embryonic MSC from NK Cell-Mediated Killing and Improves their Immunosuppressive Properties: Role of Activating and Inhibitory Receptors
More from this journal
The newest in Journal of Cell Science & Therapy.
Perspective · 2 Feb 2026
Exploring Senescence and Its Influence on Tissue Function and Therapeutic Research
Commentary · 2 Feb 2026
Metabolism Regulation and Its Influence on Therapeutic Development in Human Disease
Commentary · 2 Dec 2025
Cellular Membranes and Transport Proteins as Regulators of Homeostasis and Metabolic Coordination
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cell Science & Therapy
- SubjectBiology
- BylineArticles whose byline prints “Pampee P. Young”

